The Shaoxing facility will provide 250 m³ of reaction volume, with potential capacity exceeding 400 m³, as the CDMO expands ...
The acquisition adds GLP bioanalysis, nitrosamine impurity testing and extractables and leachables services to LGM Pharma’s ...
Lonza, the world’s leading contract development and manufacturing organisation (CDMO), announced today the expansion of its ...
As climate disruption reshapes global disease patterns and strains precision supply chains, the healthcare sector faces a ...
Eppendorf has extended its collaboration with BioLabs to the new BioLabs | TUM site in Munich, providing resident biotech ...
The dry granulation-based expansion eliminates technology transfer between development and commercial scale, with Recipharm’s ...
The collaboration will combine Sanofi’s mRNA drug candidates with ScionxBio’s AI-driven TERA platform to develop ...
Tablet coating is a critical process step in pharmaceutical production. The right coating determines where, when and how an ...
Ansell explains the key differences between cleanroom and medical gloves, highlighting contamination control, cleanliness standards and the importance of selecting suitable protection for pharmaceutic ...
The acquisition will add a Phase III-ready siRNA therapy for polycythaemia vera to Merck’s rare disease pipeline, ...
Nitrosamines are substances with an N=O (N-nitroso) functional group, and toxicologists consider them to be highly toxic ...
The firm will manufacture up to 3 million ATNAA autoinjectors for the US Defense Logistics Agency to support military medical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results